Denali Therapeutics
DNLI
DNLI
222 hedge funds and large institutions have $1.85B invested in Denali Therapeutics in 2025 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 74 increasing their positions, 81 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
9% less repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 81
29% less capital invested
Capital invested by funds: $2.61B → $1.85B (-$758M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
222
Holding in Top 10
1
Calls
$848K
Puts
$515K
Top Buyers
| 1 | +$61M | |
| 2 | +$38M | |
| 3 | +$29.9M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$25.1M |
| 5 |
Millennium Management
New York
|
+$20.9M |
Top Sellers
| 1 | -$19.2M | |
| 2 | -$13.6M | |
| 3 | -$11.6M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$11.2M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$10.2M |